Innovative pricing & payment schemes in healthcare

Health systems today face growing challenges in ensuring timely and equitable access to innovative health technologies while maintaining financial sustainability. This is especially evident with the increasing availability of high-cost medicines, such as gene and cell therapies, often launched with limited clinical evidence and high uncertainty regarding their realworld effectiveness and budgetary impact. In this context, pricing and payment schemes have been proposed as practical tools to address these challenges. As a result, pricing and reimbursement decisions are becoming more complex, as traditional models struggle to accommodate innovative technologies with unique characteristics and novel modalities of care and delivery.

This course responds to a concrete and timely need: helping professionals understand how pricing and payment mechanisms are currently leveraged, or can be strategically deployed, to balance access to innovation with affordability of the healthcare systems in the European Union.

Drawing on cutting-edge research outputs conducted within European Commission-funded research framework, specific tools, real-world cases and policy implications, the course will provide participants with comprehensive insights on different types of pricing and payment schemes for pharmaceuticals and medical devices (including annuitybased models for ATMPs, outcome-based agreements, subscription models for antibiotics, indication-based pricing for multi-use drugs), and on how to identify the most appropriate pricing models given specific objectives or needs.

The program consists of 3 days, totaling 24 equivalent hours, and is built on 3 pillars.

The program is aimed at professionals working at the interface of pricing and market access of health technologies, particularly those involved in pricing negotiations or the preparation of value dossiers. It is designed for individuals seeking to build a solid, crosscutting perspective that integrates regulatory and evaluative dimensions.

More specifically, the program addresses the needs of practitioners and industry professionals engaged in the market access of pharmaceuticals and medical devices. It is relevant both for professionals in managerial roles and for those without formal managerial responsibilities who are involved in—or wish to gain a deeper understanding of—the dynamics of pricing and reimbursement of health technologies.

Learning is never a linear journey—it is a path built together, combining specific training needs with practical tools tailored to individual challenges. Contact our team of Program Advisors, and together we will design the ideal learning path for you or your team, ensuring alignment with your goals.Your benefits:A dedicated orientation meeting, either in-person or remotely, to identify learning needs and create a customized plan. Throughout the course, you will experience a tailored welcome to introduce you to the program and foster networking between participants and instructors. Upon completion, your evaluation will become a valuable contribution for continuous improvement of the offering.How your organization benefits:Training consultation with HR managers to analyze organizational needs and develop personalized projects. Ongoing progress monitoring and a final follow-up to share results and gather feedback, ensuring constant alignment with pre-set goals.Get in touch with Patrizia Trivellato